These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 25359881)

  • 1. Investigating the role of angiogenesis in systemic lupus erythematosus.
    Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
    Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significance.
    Zhou L; Lu G; Shen L; Wang L; Wang M
    Biomed Res Int; 2014; 2014():627126. PubMed ID: 24511540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected angiogenic cytokines in systemic lupus erythematosus patients.
    Hrycek A; Janowska J; Cieślik P
    Autoimmunity; 2009 Aug; 42(5):459-66. PubMed ID: 19811263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic activity in sera of patients with systemic lupus erythematosus.
    Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
    Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors.
    Hsu C; Chen CN; Chen LT; Wu CY; Hsieh FJ; Cheng AL
    Radiology; 2005 May; 235(2):509-16. PubMed ID: 15858091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.
    Robak E; Kierstan M; Cebula B; Krawczynska A; Sysa-Jedrzejowska A; Wierzbowska A; Smolewski P; Robak T
    Lupus; 2009 Apr; 18(4):332-41. PubMed ID: 19276301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S; Ciołkiewicz M
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):179-85. PubMed ID: 17557150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.
    de Jesús GR; Lacerda MI; Rodrigues BC; Dos Santos FC; do Nascimento AP; Cristóvão Porto L; de Jesús NR; Levy RA; Klumb EM
    Arthritis Care Res (Hoboken); 2021 May; 73(5):717-721. PubMed ID: 32583963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
    Robak E; Sysa-Jedrzejewska A; Robak T
    Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations.
    Moneib HA; Salem SA; Aly DG; Khedr HT; Wafaey HA; Hassan HE
    J Dermatol; 2012 Jan; 39(1):52-7. PubMed ID: 21950586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
    Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K
    Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM; El-Kerdany TH
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients.
    Porta C; Paglino C; Imarisio I; Ganini C; Sacchi L; Quaglini S; Giunta V; De Amici M
    Oncology; 2013; 84(2):115-22. PubMed ID: 23154434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.